Technology | January 12, 2012

Varian’s Treatment Planning System Receives 510(k) Clearance

 

January 12, 2012 – Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new radiotherapy treatment planning tool designed to work with the company's Eclipse treatment planning software to reduce the amount of time needed for planning advanced treatments.

"In order to create a customized treatment plan, a clinician must take the patient's anatomical images and identify and outline the tumor and nearby organs in a process called contouring. This is critical when specifying what is to be irradiated or protected during radiotherapy treatments," said Jefferson Amacker, director, clinical solutions. "Traditionally, contouring has been a time-consuming process."

Varian has combined two techniques in Smart Segmentation Knowledge-Based Contouring, making it possible for clinicians to accomplish the contouring process more quickly:

  1. Smart Segmentation, which analyzes anatomical images, drawing on information about human anatomy to identify and outline organs and other structures, and
  2. Knowledge-Based Contouring, which allows the clinician to start the planning process by drawing on a library of expertly pre-contoured images that have important anatomical structures already outlined. The clinician then follows a special process for matching these pre-contoured images with those of the patient to create the desired contours.

"It's similar to building a house from scratch or remodeling. Remodeling is generally faster because you have something to work from," said Amacker. "Both of these tools give clinicians a head start, so that the contouring task can be more easily and quickly completed."

Smart Segmentation KBC can be used in conjunction with Varian's Eclipse treatment planning system to create treatment plans for external beam or for brachytherapy treatments. The Knowledge Based Contouring tool contains an anatomy atlas that covers all of the areas of the body most commonly treated with radiotherapy when cancer has been detected, including the breast, prostate, gynecological, lung, brain, head and neck, and many other areas of the body. Eclipse has been adopted for radiotherapy treatment planning at more than 3,000 radiation oncology clinics around the world.

For more information: www.varian.com

 

Related Content

Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares
RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital
News | Treatment Planning | January 30, 2018
Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for...
Small-Cell Lung Cancer Patients Face Barriers to Standard-of-Care Treatment
News | Lung Cancer | January 29, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the...
Overlay Init